HESC-RPE

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
301	黄斑ジストロフィー	2

301. 黄斑ジストロフィー

臨床試験数 : 46 / 薬物数 : 42 - (DrugBank : 11) / 標的遺伝子数 : 9 - 標的パスウェイ数 : 67

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02941991 (ClinicalTrials.gov)	January 16, 2013	20/10/2016	A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human E ...	Follow-up to 5 Years of a Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the S ...	Stargardt's Macular Dystrophy	Biological: hESC-RPE	Astellas Institute for Regenerative Medicine	NULL	Completed	18 Years	N/A	All	12	Phase 1/2	United Kingdom
2	NCT01469832 (ClinicalTrials.gov)	December 13, 2011	8/11/2011	Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal ...	A Phase I/II, Open-Label, Multi-Center, Prospective Study to Determine the Safety and Tolerability o ...	Stargardt's Macular Dystrophy	Biological: MA09-hRPE	Astellas Institute for Regenerative Medicine	NULL	Completed	18 Years	N/A	All	12	Phase 1/Phase 2	United Kingdom

First Previous1Next Last